INGEVITY CORP (NGVT)

US45688C1071 - Common Stock

53.23  -0.62 (-1.15%)

Fundamental Rating

3

Overall NGVT gets a fundamental rating of 3 out of 10. We evaluated NGVT against 84 industry peers in the Chemicals industry. While NGVT is still in line with the averages on profitability rating, there are concerns on its financial health. NGVT has a valuation in line with the averages, but on the other hand it scores bad on growth.



4

1. Profitability

1.1 Basic Checks

NGVT had positive earnings in the past year.
In the past year NGVT had a positive cash flow from operations.
Of the past 5 years NGVT 4 years were profitable.
Each year in the past 5 years NGVT had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -4.37%, NGVT is doing worse than 73.81% of the companies in the same industry.
The Return On Equity of NGVT (-19.73%) is worse than 83.33% of its industry peers.
The Return On Invested Capital of NGVT (7.03%) is better than 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NGVT is above the industry average of 7.44%.
Industry RankSector Rank
ROA -4.37%
ROE -19.73%
ROIC 7.03%
ROA(3y)4.1%
ROA(5y)5.73%
ROE(3y)15.66%
ROE(5y)21.97%
ROIC(3y)10.42%
ROIC(5y)10.89%

1.3 Margins

NGVT has a better Operating Margin (12.09%) than 67.86% of its industry peers.
NGVT's Operating Margin has declined in the last couple of years.
The Gross Margin of NGVT (27.06%) is comparable to the rest of the industry.
NGVT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 12.09%
PM (TTM) N/A
GM 27.06%
OM growth 3Y-14.33%
OM growth 5Y-8.22%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.02%
GM growth 5Y-5.38%

2

2. Health

2.1 Basic Checks

NGVT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, NGVT has less shares outstanding
NGVT has less shares outstanding than it did 5 years ago.
The debt/assets ratio for NGVT is higher compared to a year ago.

2.2 Solvency

The Debt to FCF ratio of NGVT is 17.21, which is on the high side as it means it would take NGVT, 17.21 years of fcf income to pay off all of its debts.
NGVT's Debt to FCF ratio of 17.21 is in line compared to the rest of the industry. NGVT outperforms 48.81% of its industry peers.
NGVT has a Debt/Equity ratio of 2.48. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of NGVT (2.48) is worse than 89.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.48
Debt/FCF 17.21
Altman-Z N/A
ROIC/WACC0.91
WACC7.69%

2.3 Liquidity

NGVT has a Current Ratio of 1.90. This is a normal value and indicates that NGVT is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NGVT (1.90) is comparable to the rest of the industry.
NGVT has a Quick Ratio of 1.90. This is a bad value and indicates that NGVT is not financially healthy enough and could expect problems in meeting its short term obligations.
NGVT has a Quick ratio of 0.98. This is in the lower half of the industry: NGVT underperforms 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 0.98

3

3. Growth

3.1 Past

NGVT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.87%.
Measured over the past years, NGVT shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.09% on average per year.
NGVT shows a decrease in Revenue. In the last year, the revenue decreased by -2.29%.
Measured over the past years, NGVT shows a quite strong growth in Revenue. The Revenue has been growing by 8.34% on average per year.
EPS 1Y (TTM)-38.87%
EPS 3Y-6.98%
EPS 5Y-1.09%
EPS growth Q2Q-52.29%
Revenue 1Y (TTM)-2.29%
Revenue growth 3Y11.64%
Revenue growth 5Y8.34%
Revenue growth Q2Q-13.37%

3.2 Future

The Earnings Per Share is expected to grow by 13.34% on average over the next years. This is quite good.
The Revenue is expected to decrease by -1.18% on average over the next years.
EPS Next Y-6.15%
EPS Next 2Y13.95%
EPS Next 3Y13.34%
EPS Next 5YN/A
Revenue Next Year-11.71%
Revenue Next 2Y-3.05%
Revenue Next 3Y-1.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

5

4. Valuation

4.1 Price/Earnings Ratio

NGVT is valuated correctly with a Price/Earnings ratio of 15.89.
Compared to the rest of the industry, the Price/Earnings ratio of NGVT indicates a somewhat cheap valuation: NGVT is cheaper than 71.43% of the companies listed in the same industry.
NGVT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.02.
A Price/Forward Earnings ratio of 10.46 indicates a reasonable valuation of NGVT.
Based on the Price/Forward Earnings ratio, NGVT is valued cheaper than 84.52% of the companies in the same industry.
NGVT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 20.58.
Industry RankSector Rank
PE 15.89
Fwd PE 10.46

4.2 Price Multiples

70.24% of the companies in the same industry are more expensive than NGVT, based on the Enterprise Value to EBITDA ratio.
NGVT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 22.23
EV/EBITDA 10.5

4.3 Compensation for Growth

NGVT's earnings are expected to grow with 13.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.95%
EPS Next 3Y13.34%

0

5. Dividend

5.1 Amount

No dividends for NGVT!.
Industry RankSector Rank
Dividend Yield N/A

INGEVITY CORP

NYSE:NGVT (5/7/2024, 1:52:33 PM)

53.23

-0.62 (-1.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.93B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 15.89
Fwd PE 10.46
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.37%
ROE -19.73%
ROCE
ROIC
ROICexc
ROICexgc
OM 12.09%
PM (TTM) N/A
GM 27.06%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 2.48
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.9
Quick Ratio 0.98
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-38.87%
EPS 3Y-6.98%
EPS 5Y
EPS growth Q2Q
EPS Next Y-6.15%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.29%
Revenue growth 3Y11.64%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y